NCT Number: NCT00032981
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.
Looking for future studies?
Notify MeKey information
Age range
18 year–99 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Haight Ashbury Free Clinics, San Francisco, California, United States
About this study
Participants seeking treatment at the participating CTPs will be randomly assigned to either "standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses, days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes will include motivation, psychosocial functioning, HIV risk behaviors, treatment utilization, and patient satisfaction. Process assessments will include measures of the working alliance as well as therapist adherence/competence ratings which will evaluate how effectively MET/MI was implemented. Participating CTPs will implement one of two independent protocols, depending on which is the best suited or feasible for the intake procedures at their clinic. Thus, following an invitation to participate, explanation of the study, and provision of informed consent, patients would complete a brief assessment battery followed by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1 individual standard assessment/evaluation session.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Individuals will be eligible for the protocol who:
- Are seeking outpatient treatment for any substance use disorder
- Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped)
- Are able to understand and provide written informed consent
Exclusion criteria
Individuals will be excluded who:
- Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment
- Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment
Treatment and study plan
Primary outcomes
-
Drug use
-
Retention
-
HIV risk behaviors
-
Psychosocial functioning
Sponsors and collaborators
Lead sponsor
Yale University
Other
Registry information
Official study title
Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Important dates
- Study start
- 2001
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Apr 8, 2002
- Registry last updated
- Jan 12, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
NCT06629493
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Gijón, Principality of Asturias, Spain
View Trial DetailsGrowing Together: Women in Opioid Treatment and Their Infants
NCT03866694
Behavior, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial DetailsFirst Face Training Evaluation in Tribal Communities
NCT05998005
Behavior, Behavior, Addictive
Bonners Ferry, Idaho, United States
View Trial DetailsResearch on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
NCT01117753
Anxiety Disorder, Anxiety Disorders
Charleston, South Carolina, United States
View Trial Details